February 22nd, 2025

NIH funding freeze stalls applications on $1.5B in medical research funds

The NIH has paused new grant applications, delaying $1.5 billion in funding and stalling 16,000 applications due to the Trump administration's actions, raising concerns about future medical research funding.

Read original articleLink Icon
NIH funding freeze stalls applications on $1.5B in medical research funds

The National Institutes of Health (NIH) has halted the consideration of new grant applications, resulting in a delay of approximately $1.5 billion in funding for medical research. This freeze is attributed to the Trump administration's decision to block the NIH from posting new notices in the Federal Register, which is necessary for federal meetings to occur. Consequently, around 16,000 grant applications are currently stalled, affecting research into various diseases, including heart disease, cancer, and Alzheimer's. NIH officials are hopeful that the freeze will be lifted soon to prevent further disruption. The NIH, with an annual budget of nearly $48 billion, is the largest public funder of biomedical research globally. The freeze has led to frustration among researchers and committee members who are unable to review and provide feedback on critical research proposals. While some observers argue that a temporary pause for review is typical for a new administration, others express concern that the current approach may dismantle established funding processes. Additionally, the NIH has faced workforce cuts and proposed changes to funding structures, raising fears about the future of medical research funding.

- NIH has paused new grant applications, delaying $1.5 billion in funding.

- Approximately 16,000 grant applications are currently stalled.

- The funding freeze is linked to the Trump administration's actions regarding Federal Register notices.

- Researchers express frustration over the inability to review critical proposals.

- Concerns grow over potential long-term impacts on the NIH and medical research funding.

Link Icon 3 comments
By @fabian2k - about 2 months
They're simply trying to eliminate most academic research, there aren't many other plausible explanations here. Blocking the grant reviews might look temporary, but these delays pile up and at some point it simply won't be possible to properly review the grants in time.

And this is not the only way they're interfering with scientific research, the hard cap on indirect costs is probably the other most significant event. And all of this is on extremely short notice (or actually retroactive as it applies to grants that are already approved), which makes it even more destructive.

By @jjtheblunt - about 2 months
This article is interesting, considering it presents several observations, past the first several paragraphs, which say this is normal upon administration changes, and others saying long overdue. the first paragraphs cast it in a negative light. At least NPR showed distinct viewpoints.

> Some outside observers defended the situation.

> "A temporary pause in publicizing or funding new grants in order to review them is typical for a new administration," Judge Glock, director of research and a senior fellow at the Manhattan Institute, a conservative think tank, wrote in an email to NPR."

By @jmclnx - about 2 months
Time to be bitter, if there is any good news, it is this will affect the oligarchs. Medical issues should be a concern to everyone.